Pseudoexfoliation may be a risk factor for peripheral vascular disease

Article

Cataract and pseudoexfoliation (PEX) patients with a low ankle brachial index (ABI) are at higher risk of peripheral vascular disease (PVD)

Cataract and pseudoexfoliation (PEX) patients with a low ankle brachial index (ABI) are at higher risk of peripheral vascular disease (PVD), according to a study in Eye.

Dr M.R. Praveen et al., Iladevi Cataract and IOL Research Center, Ahmedabad, India, conducted an observational age-matched case-control study of 160 age-related cataract patients who were no less than 60 years old. Forty PEX patients with cataracts were compared with a control group of 120 cataract patients without PEX. The subjects medical history such as hypertension, diabetes mellitus, cerebrovascular stroke and ischaemic heart disease were taken into consideration.

The risk of PVD among the patients was determined through the measurement of ABI by colour Doppler imaging of the brachia and dorsalis pedis artery. From prio knowledge that a low ABI indicates an increased risk of PVD each patient's lowest mean ABI was recorded as the main outcome measure.

The lowest ABI in the controls was 0.98±0.03 and 0.88±0.02 in the PEX group. It was found that there was a strong correlation between presence of PEX and ABI, with the odds of low ABI being 150 times more than the control group.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.